In our present work, seven potentially prognostic biomarker genes (CCNB2, CCNB1, CDC20, PTTG1, BUB1B, TTK and CCNE2) that were remarkably enriched in the cell cycle pathway and significantly associated with BC prognosis were screened and evaluated via bioinformatics methods. This evidence concerns the gene CDC20 and breast cancer.